Publications by authors named "Kurt Lock"

Claim this Profile
R
Responding to an evolving crisis: Meeting the needs of a growing population who smoke their unregulated substances.
Jessica C Xavier, Charlene Burmeister, Iesha Henderson, Kali-Olt Rufus-Sedgemore, Amber Streukens, Kurt Lock

Can J Public Health· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'This is PEEP' participatory qualitative study: learning from a provincial consultation and advisory group of people with lived and living experience of substance use in British Columbia, Canada.
Kerolos Daowd, Kurt Lock, Amirnima Danaei, Charlene Burmeister, Paul Choisil

BMJ Open· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access and barriers to safer supply prescribing during a toxic drug emergency: a mixed methods study of implementation in British Columbia, Canada.
Karen A Urbanoski, Thea van Roode, Marion Selfridge, Katherine C Hogan, James Fraser, Kurt Lock

Subst Abuse Treat Prev Policy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating the nexus between British Columbia's public consumption and decriminalization policies of illegal drugs.
Farihah Ali, Justine Law, Cayley Russell, Jean-Francois Crépault, João Castel-Branco Goulão, Kurt Lock

Health Res Policy Syst· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations with experience of non-fatal opioid overdose in British Columbia, Canada: a repeated cross sectional survey study.
Max Ferguson, Paul Choisil, Jessica Lamb, Charlene Burmeister, Cheri Newman, Kurt Lock

Harm Reduct J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Injectable Opioid Agonist Treatment (iOAT) on Involvement in Criminalized Activities: A Secondary Analysis from a Clinical Trial in Vancouver, BC.
Sophia Dobischok, Daphne Guh, Kirsten Marchand, Scott MacDonald, Kurt Lock

Subst Abuse Rehabil· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doing community-based research during dual public health emergencies (COVID and overdose).
Phoenix Beck McGreevy, Shawn Wood, Erica Thomson, Charlene Burmeister, Heather Spence, Kurt Lock

Harm Reduct J· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Awareness, predictors and outcomes of drug alerts among people who access harm reduction services in British Columbia, Canada: findings from a 2021 cross-sectional survey.
Kerolos Daowd, Max Ferguson, Lisa Liu, Jackson Loyal, Kurt Lock

BMJ Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking identified as preferred mode of opioid safe supply use; investigating correlates of smoking preference through a 2021 cross-sectional study in British Columbia.
Ariba Kamal, Max Ferguson, Jessica C Xavier, Lisa Liu, Brittany Graham, Kurt Lock

Subst Abuse Treat Prev Policy· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.
Annie Foreman-Mackey, Jessica Xavier, Jenny Corser, Mathew Fleury, Kurt Lock

BMC Public Health· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crises.
Kaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, Kurt Lock, Adam Easterbrook

Harm Reduct J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Testing Client Preferences for Accessing Injectable Opioid Agonist Treatment (iOAT): A Pilot Study.
Sophia Dobischok, Rebecca K Metcalfe, Elizabeth Angela Matzinger, Kurt Lock, Scott Harrison

Patient Prefer Adherence· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study.
Heather Palis, Chloé Xavier, Sabina Dobrer, Roshni Desai, Kali-Olt Sedgemore, Kurt Lock

BMC Public Health· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline development in harm reduction: Considerations around the meaningful involvement of people who access services.
Alison Adams, Max Ferguson, Alissa M Greer, Charlene Burmeister, Kurt Lock

Drug Alcohol Depend Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motivations for concurrent use of uppers and downers among people who access harm reduction services in British Columbia, Canada: findings from the 2019 Harm Reduction Client Survey.
Abigail Steinberg, Amiti Mehta, Kristi Papamihali, Christine D Lukac, Sara Young, Kurt Lock

BMJ Open· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying behaviours for survival and wellness among people who use methamphetamine with opioids in British Columbia: a qualitative study.
Jenny Corser, Heather Palis, Mathew Fleury, Jess Lamb, Kurt Lock

Harm Reduct J· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
Christine D Lukac, Abigail Steinberg, Kristi Papamihali, Amiti Mehta, Kurt Lock

Int J Drug Policy· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating opioid preference to inform safe supply services: A cross sectional study.
Max Ferguson, Amrit Parmar, Kristi Papamihali, Anita Weng, Kurt Lock

Int J Drug Policy· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use research.
Kirsten Marchand, Heather Palis, Daphne Guh, Kurt Lock, Scott MacDonald

J Subst Abuse Treat· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment.
Heather Palis, Kirsten Marchand, Gerald Spike Peachey, Jordan Westfall, Kurt Lock

Subst Abuse Treat Prev Policy· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol.
Bohdan Nosyk, Amanda Slaunwhite, Karen Urbanoski, Natt Hongdilokkul, Heather Palis, Kurt Lock

BMJ Open· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with injectable hydromorphone: Comparing retention in double blind and open label treatment periods.
Eugenia Oviedo-Joekes, Heather Palis, Daphne Guh, Kirsten Marchand, Suzanne Brissette, Kurt Lock

J Subst Abuse Treat· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between nicotine dependence and physical health among people receiving injectable diacetylmorphine or hydromorphone for the treatment of chronic opioid use disorder.
Heather Palis, Kirsten Marchand, Mohammad Karamouzian, Scott MacDonald, Scott Harrison, Kurt Lock

Addict Behav Rep· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence.
Eugenia Oviedo-Joekes, Heather Palis, Daphne Guh, Kirsten Marchand, Suzanne Brissette, Kurt Lock

Drug Alcohol Rev· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.
Heather Palis, Kirsten Marchand, Daphne Guh, Suzanne Brissette, Kurt Lock

Subst Abuse Treat Prev Policy· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis